This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , Simpson , PhD, MD, Founder and CEO of Simpson Interventions. This designation recognizes the transformative potential of our technology in addressing a critical unmet need in the treatment of patients with coronary chronic total occlusions.
Emrah Erdogan , Yüzüncü Yil University, Van, Türkiye These leading experts provided in-depth insights into the latest advancements in IVUS, OCT, and FFR technologies, offering participants the opportunity to engage with cutting-edge clinical practices. Ibrahim Halil Tanboga , Hisar Intercontinental Hospital, Türkiye Assoc. www.adncoe.com
Emrah Erdogan , Van Yüzüncü Yıl University Hospital, Türkiye These leading experts provided in-depth insights into the latest advancements in IVUS, OCT, and FFR technologies, offering participants the opportunity to engage with cutting-edge clinical practices. Ibrahim Halil Tanboga , Hisar Intercontinental Hospital, Türkiye Assoc.
One of the defining moments of the training was the hands-on experience with state-of-the-art Abbott device, empowering attendees to master the latest technologies in cardiovascular care. The palpable excitement in the room as doctors interacted with these innovative tools underscored the practical significance of our training.
One of the defining moments of the training was the hands-on experience with state-of-the-art Abbott device, empowering attendees to master the latest technologies in cardiovascular care. The palpable excitement in the room as doctors interacted with these innovative tools underscored the practical significance of our training.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content